Skip to main content
. Author manuscript; available in PMC: 2008 May 21.
Published in final edited form as: Mol Pharmacol. 2007 Dec 21;73(3):1029–1036. doi: 10.1124/mol.107.043869

Figure 5.

Figure 5

1’-OH midazolam formation by human CYP2C and CYP3A enzymes. The final concentration of midazolam in the incubations was 25 μM and 20 pmol of enzyme was used. After a preincubation of 5 min the reaction was started by adding a NADPH-regenerating system and the mixture was subsequently incubated for 10 minutes. All values are the means of duplicate determinations.